{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Abbott", "item": "https://www.patentleaderboard.com/2021/company/abbott"}, {"@type": "ListItem", "position": 4, "name": "Shanker Gupta", "item": "https://www.patentleaderboard.com/2021/inventor/fl:sh_ln:gupta-23"}]}

Home › 2021 › Abbott › Shanker Gupta

Shanker Gupta — 1 Patent in 2021

MRMriglobal: 1 patents #1 of 4Top 25%

TSThe United States Of America, As Represented By The Secretary, Department Of Health And Human Services: 1 patents #101 of 447Top 25%

Vernon Hills, IL: #26 of 88 inventorsTop 30%

Illinois: #2,747 of 8,822 inventorsTop 35%

Overall (2021): #264,429 of 548,734Top 50%

1 Patents 2021

Issued Patents 2021

Showing 1–1 of 1 patents

Patent #	Title	Co-Inventors	Date
10913709	STAT3 inhibitor formulation	Robert H. Shoemaker, Michael W. Lovell, Jonathan White	2021-02-09

Shanker Gupta — 1 Patent in 2021

Issued Patents 2021

Patent Widget